trial

Enhancing Educational and Vocational Recovery in Adolescents and Young Adults With Early Psychosis Through Supported Employment and Education.

NCTId NCT05824117
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 184 (estimated)
Sponsored by Charite University, Berlin, Germany
Primary completion 2024-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
184 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2022-10-18
Primary completion
2024-12-31
Eligibility
ALL · 16 Years · 35 Years

Interventions & indications

Drugs
Individual Placement and Support (IPS)

Sponsors

Charite University, Berlin, GermanyLead Sponsor

Investigators

1
Andreas Bechdolf, Prof. Dr.Principal Investigator

Sites

6 total
Reichenau, GermanyMünchen, GermanyUlm, GermanyBerlin, GermanyBerlin, GermanyHamburg, Germany

Facts & assertions

4 sourced
Enrollment
184
Phase
NA
Primary Completion Date
2024-12-31
Status
UNKNOWN
relationships
The graph out of here
drug
Individual Placement and Support (IPS)
drug
lead_sponsor
Charite University, Berlin, Germany
company
indication
Persistent Delusional Disorder
indication
Schizoaffective Disorder
indication
Acute and Transient Psychotic Disorder, Unspecified
indication
investigator
Andreas Bechdolf, Prof. Dr.
person